Trine Tang Christensen

Trine Tang Christensen

Auto-generated profile, based on publicly available information

Trine Tang Christensen

Steno Diabetes Center Aalborg, Aalborg University Hospital , 9260 Gistrup

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in Behavioural Pharmacology
Verified
Journal Article
Closed access
KHKim Henningsen
Kim Henningsen
MDMads Dyrvig
Mads Dyrvig
EBElena V. Bouzinova
Elena V. Bouzinova
SCSofie Christiansen
Sofie Christiansen
TCTrine Christensen
Trine Christensen
OWOve Wiborg
Ove Wiborg
In the present study we report the finding that the quality of maternal care, in early life, increased the susceptibility to stress exposure in adulthood, when rats were exposed to the chronic mild stress paradigm. Our results indicate that high, as opposed to low maternal care, predisposed rats to a differential stress-coping ability. Thus rats fostered by low maternal care dams became more prone to adopt a stress-susceptible phenotype developing an anhedonic-like condition. Moreover, low maternal care offspring had lower weight gain and lower locomotion, with no additive effect of stress. Subchronic exposure to chronic mild stress induced an increase in faecal corticosterone metabolites, which was only significant in rats from low maternal care dams. Examination of glucocorticoid receptor exon 17 promoter methylation in unchallenged adult, maternally characterized rats, showed an insignificant tendency towards higher total cytosine methylation in rats from low maternal care dams. Assessment of methylation in the resilient versus anhedonic-like rat phenotypes, revealed only minor differences. Thus, maternal care status seems to be a strong predictor or trait marker for the behavioural phenotype.

8 November 2012 in Journal of Psychopharmacology
Verified
Journal Article
Closed access
CBChristina F Bisgaard
Christina F Bisgaard
SBSteffen Yde Bak
Steffen Yde Bak
TCTrine Christensen
Trine Christensen
OJOle N. Jensen
Ole N. Jensen
JEJan J Enghild
Jan J Enghild
OWOve Wiborg
Ove Wiborg
Extensive preclinical research has focused at unravelling the underlying molecular mechanisms leading to depression and recovery. In this study, we investigated the quantitative changes in protein abundance in the ventral hippocampal granular cell layer. We compared different phenotypes from the chronic mild stress (CMS) model of depression using chronic administration with two selective serotonin reuptake inhibitors (SSRIs), escitalopram and sertraline. We isolated granular cells using Laser-Capture Microdissection (LCM) and we identified their regulated proteins using two-dimensional (2D) differential gel electrophoresis (DIGE) and tandem mass spectrometry (MS/MS). The majority of the proteins we identified were enzymes involved in different metabolic activities. Additional proteins were functionally classified as vesicular proteins and immune system proteins. Rab GDP dissociation inhibitor alpha (GDIA) and syntaxin-binding protein 1 (STXB1) were potential markers for stress reactivity. Dynamin 1 (DYN1), glutathione S-transferase omega-1 (GSTO1) and peroxiredoxin (PRDX6) were associated with treatment response. In addition, an imbalance between different post-translationally modified versions of DYN1 and GSTO1 potentially accounted for SSRI treatment refraction. In the present study, we searched for new markers of stress reactivity and treatment response as well as any underlying molecular mechanisms correlating to the development of anhedonia and antidepressant therapy refraction. Our results pointed towards an essential role of post-translational modifications in both vesicular and immune protein systems.

4 June 2024 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Open access
SRSidsel L. Rathcke
Sidsel L. Rathcke
MSMarianne M. Sinding
Marianne M. Sinding
TCTrine T. Christensen
Trine T. Christensen
NUNiels Uldbjerg
Niels Uldbjerg
OCOle Bjarne Christiansen
Ole Bjarne Christiansen
ASAnne N. W. Sørensen
Anne N. W. Sørensen
Objective: To compare ultrasound‐assessed fetal head circumference (HC), abdominal circumference (AC), HC/AC ratio, and estimated fetal weight (EFW) in prediction of large‐for‐gestational‐age (LGA) at birth in pregnancies affected by type 1 (T1DM) and type 2 (T2DM) diabetes.Methods: This retrospective cohort study included all women with T1DM and T2DM giving birth to singletons between 2010 and 2019 at Aalborg University Hospital, Denmark. Ultrasound scans were performed at 16, 20, 28 and 34 weeks of pregnancy. LGA was defined as birth weight deviation of 15% or greater from the expected for gestational age (≥90th centile). Prediction of LGA was assessed by logistic regression adjusted for maternal characteristics and glycated hemoglobin (HbA1c) and area under the receiver operating characteristics curve (AUC).Results: Among 180 T1DM pregnancies, 118 (66%) had an LGA neonate at birth. At 28 weeks of pregnancy, they were predicted with AUCHC/AC = 0.67, AUCAC = 0.85, and AUCEFW = 0.86. The multivariate analysis did not improve the predictive performance of the HC/AC ratio or AC. Among 87 T2DM pregnancies, 36 (41%) had an LGA neonate at birth. At 28 weeks, they were predicted with AUCHC/AC = 0.73, AUCAC = 0.83, and AUCEFW = 0.87. In T2DM, the multivariate analysis significantly improved the predictive performance for both HC/AC ratio and AC from 20 weeks of pregnancy.Conclusion: In T1DM and T2DM pregnancies, LGA is characterized by a general fetal overgrowth including both AC and HC. Therefore, AC and EFW perform better than the HC/AC ratio in the prediction of LGA. In T2DM, as opposed to T1DM, the predictive performance was improved by the inclusion of maternal characteristics and HbA1c in the analysis.

9 September 2025 in Journal of the Endocrine Society
Verified
Journal Article
Open access
AKAnna Sofie Koefoed
Anna Sofie Koefoed
POPer Ovesen
Per Ovesen
JFJens Fuglsang
Jens Fuglsang
AFAstrid Fur
Astrid Fur
DJDorte Moeller Jensen
Dorte Moeller Jensen
UKUlla Kampmann
Ulla Kampmann
Context: The prevalence of type 2 diabetes (T2DM) in pregnancy is increasing rapidly worldwide. Consequently, there is a need to gain more knowledge about pregnant women with T2DM. Objective: The current study aimed to assess the prevalence of cardiometabolic risk factors and comorbidities in women with T2DM before and during pregnancy, and to evaluate associations with adverse obstetric and perinatal outcomes. A comparison between women with preexisting T2DM (P-T2DM) and women with T2DM first recognized during pregnancy (N-T2DM) was also performed. Design: A retrospective Danish national population-based cohort study, including all pregnancies in women with T2DM, giving birth to a live infant after 24 weeks of gestation, from 2004 until 2019. Results: The population included 1297 pregnancies in women with T2DM (1207 P-T2DM, 90 N-T2DM). Before pregnancy, 20.4% smoked, 13.4% had chronic hypertension, 12.5% had dyslipidemia, and 63.1% had obesity. Only 58.6% of women with P-T2DM entered pregnancy with hemoglobin A1c (HbA1c) < 53 mmol/mol (7.0%). During pregnancy, 73.4% had an excessive weight gain, and 21.6% attained a median HbA1c < 38 mmol/mol (5.6%). Preeclampsia was observed in 9.1% of women, preterm delivery in 19.0%, and large-for-gestational-age birthweight in 32.2% of infants. Obstetric and perinatal outcomes were similar in women with P-T2DM and N-T2DM. All modifiable exposures were associated with one or more severe adverse outcomes. Conclusion: Cardiometabolic risk factors are prevalent in pregnant women with T2DM and are associated with severe adverse outcomes for mother and child.

5 September 2025 in Open Heart
Verified
Journal Article
Open access
PDF file
ÁOÁsa Wraae Olsen
Ása Wraae Olsen
ASAnne Nødgaard Weidemann Sørensen
Anne Nødgaard Weidemann Sørensen
SRSidsel Linneberg Rathcke
Sidsel Linneberg Rathcke
TCTrine Tang Christensen
Trine Tang Christensen
JFJens Brøndum Frøkjær
Jens Brøndum Frøkjær
TZTomas Zaremba
Tomas Zaremba
Background: Evidence regarding cardiovascular adaptation to pregnancy in women with pregestational diabetes is limited. Our study aimed to describe left ventricular (LV) remodelling and vascular adaptation to pregnancy in women with type 1 diabetes. Methods: In this prospective cohort study, three consecutive cardiac MRI scans were conducted on age-matched and BMI-matched pregnant women with pregestational type 1 diabetes and pregnant women without diabetes. The scans were performed at gestational weeks 15–20, 26–30 and 34–37 from November 2020 to April 2023. Data collection and analysis included LV imaging results, brachial blood pressure and stroke volume derived functional vascular parameters. Results: The study included 24 women with pregestational type 1 diabetes and 39 controls. Compared with controls, women with type 1 diabetes had significantly reduced LV end-diastolic volume index: 64.2±11.1 mL/m 2 vs 77.6±13.9 mL/m 2 (p<0.001), reduced end-systolic volume index: 26.0±7.3 mL/m 2 vs 33.5±7.7 mL/m 2 (p=0.003), increased concentricity: 0.84±0.13 g/mL vs 0.68±0.10 g/mL (p<0.001), reduced stroke volume index: 38.2±7.2 mL/m 2 vs 44.1±8.4 mL/m 2 (p=0.008), reduced cardiac index: 3.37±0.55 L/min/m 2 vs 3.62±0.51 L/min/m 2 (p=0.046), reduced global longitudinal strain: −13.5±2.3% vs −15.2±2.1% (p=0.04), increased myocardial T1 values: 998±28 ms vs 983±25 ms (p=0.03), increased systolic blood pressure: 128.1±7.8 mmHg vs 117.4±11.1 mmHg (p=0.007), increased mean arterial pressure: 94.8±6.7 mmHg vs 88.1±9.7 mmHg (p=0.03), increased total peripheral vascular resistance: 28.9±5.3 mmHg·min·m 2 /L vs 24.7±4.0 mmHg·min·m 2 /L (p=0.001), and reduced total arterial compliance: 0.79±0.19 mL/m 2 /mmHg vs 1.02±0.21 mL/m 2 /mmHg (p<0.001). Conclusion: Our study provides evidence of impaired LV remodelling and suboptimal vascular adaptation to pregnancy in women with type 1 diabetes when compared to women without diabetes. The clinical implications of these findings, particularly their association with the development of later cardiovascular disease, require further investigation.